CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2021	$ 8	$ 633,795	$ (545,804)	$ 87,999
Balance, shares at Dec. 31, 2021	76,731,940
Stockholders' Equity (Deficit)
Issuance of common stock upon exercise of stock options		514		514
Issuance of common stock upon exercise of stock options, shares	137,502
Issuance of common stock in connection with employee stock purchase plan		940		940
Issuance of common stock in connection with employee stock purchase plan, shares	332,377
Stock-based compensation expense		16,964		16,964
Net Income (Loss)			(71,038)	(71,038)
Balance at Dec. 31, 2022	$ 8	652,213	(616,842)	35,379
Balance, shares at Dec. 31, 2022	77,201,819
Stockholders' Equity (Deficit)
Issuance of common stock upon exercise of stock options		551		551
Issuance of common stock upon exercise of stock options, shares	141,952
Issuance of common stock in connection with employee stock purchase plan		851		851
Issuance of common stock in connection with employee stock purchase plan, shares	290,691
Issuance of common stock, net of issuance costs	$ 4	117,257		117,261
Issuance of common stock, net of issuance costs, shares	36,934,926
Issuance of common stock upon vesting of restricted stock units (in shares)	393,805
Stock-based compensation expense		17,825		17,825
Net Income (Loss)			(80,736)	(80,736)
Balance at Dec. 31, 2023	$ 12	788,697	(697,578)	91,131
Balance, shares at Dec. 31, 2023	114,963,193
Stockholders' Equity (Deficit)
Issuance of common stock upon exercise of stock options		14,741		$ 14,741
Issuance of common stock upon exercise of stock options, shares	3,112,976			3,112,976
Issuance of common stock in connection with employee stock purchase plan		1,016		$ 1,016
Issuance of common stock in connection with employee stock purchase plan, shares	213,131
Issuance of common stock, net of issuance costs	$ 3	316,350		316,353
Issuance of common stock, net of issuance costs, shares	32,413,560
Issuance of common stock upon exercise of conversion option	$ 1	52,499		52,500
Issuance of common stock upon exercise of conversion option, shares	5,769,232
Issuance of common stock upon vesting of restricted stock units (in shares)	1,277,398
Stock-based compensation expense		33,109		33,109
Net Income (Loss)			(193,506)	(193,506)
Balance at Dec. 31, 2024	$ 16	$ 1,206,412	$ (891,084)	$ 315,344
Balance, shares at Dec. 31, 2024	157,749,490